Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark B Leick

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Journal for Immunotherapy of Cancer|January 8, 2022
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)Marc Wehrli, Kathleen Gallagher, Yi-Bin Chen, et al.
Cancer Cell|April 22, 2022
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemiaMark B Leick, Harrison Silva, Irene Scarfò, et al.
Nature Communications|November 2, 2025
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical modelsFilippo Birocchi, Antonio J Almazan, Aiyana Parker, et al.
Blood Cancer Discovery|January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic MalignanciesStefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Blood|March 31, 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatmentViktoria Blumenberg, Benjamin R Puliafito, Charlotte E Graham, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Science Translational Medicine|June 5, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimeticsFelix Korell, Michael L Olson, Diego Salas-Benito, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Nature Communications|December 10, 2025
Tuning CAR-T cells by targeting cancer-associated glycan in pancreatic cancerSangwoo Park, Cassidy E Ho, Eli P Darnell, et al.
Leukemia|December 20, 2023
Chemical genetic control of cytokine signaling in CAR-T cells using lenalidomide-controlled membrane-bound degradable IL-7Michael C Kann, Emily M Schneider, Antonio J Almazan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 13, 2025
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancerAlexander Armstrong, Graziella van der Plancke, Sae Nishiguchi, et al.
Journal for Immunotherapy of Cancer|January 8, 2022
Single-center experience using anakinra for steroid-refractory immune effector cell-associated neurotoxicity syndrome (ICANS)Marc Wehrli, Kathleen Gallagher, Yi-Bin Chen, et al.
Cancer Cell|April 22, 2022
Non-cleavable hinge enhances avidity and expansion of CAR-T cells for acute myeloid leukemiaMark B Leick, Harrison Silva, Irene Scarfò, et al.
Nature Communications|November 2, 2025
On-target off-tumor toxicity of claudin18.2-directed CAR-T cells in preclinical modelsFilippo Birocchi, Antonio J Almazan, Aiyana Parker, et al.
Blood Cancer Discovery|January 11, 2022
Blockade or Deletion of IFNγ Reduces Macrophage Activation without Compromising CAR T-cell Function in Hematologic MalignanciesStefanie R Bailey, Sonika Vatsa, Rebecca C Larson, et al.
Blood|March 31, 2025
Cyclophosphamide mitigates non-ICANS neurotoxicities following ciltacabtagene autoleucel treatmentViktoria Blumenberg, Benjamin R Puliafito, Charlotte E Graham, et al.
Blood Advances|August 3, 2021
Clonal hematopoiesis in patients receiving chimeric antigen receptor T-cell therapyPeter G Miller, Adam S Sperling, Elliott J Brea, et al.
Science Translational Medicine|June 5, 2024
Comparative analysis of Bcl-2 family protein overexpression in CAR T cells alone and in combination with BH3 mimeticsFelix Korell, Michael L Olson, Diego Salas-Benito, et al.
Pageof 6